SG11202108840XA - Producing compositions comprising two or more antibodies. - Google Patents
Producing compositions comprising two or more antibodies.Info
- Publication number
- SG11202108840XA SG11202108840XA SG11202108840XA SG11202108840XA SG11202108840XA SG 11202108840X A SG11202108840X A SG 11202108840XA SG 11202108840X A SG11202108840X A SG 11202108840XA SG 11202108840X A SG11202108840X A SG 11202108840XA SG 11202108840X A SG11202108840X A SG 11202108840XA
- Authority
- SG
- Singapore
- Prior art keywords
- antibodies
- producing compositions
- compositions
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C07K2317/526—CH3 domain
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19157286 | 2019-02-14 | ||
| EP19178542 | 2019-06-05 | ||
| PCT/NL2020/050080 WO2020167122A1 (en) | 2019-02-14 | 2020-02-13 | Producing compositions comprising two or more antibodies. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202108840XA true SG11202108840XA (en) | 2021-09-29 |
Family
ID=69771002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202108840XA SG11202108840XA (en) | 2019-02-14 | 2020-02-13 | Producing compositions comprising two or more antibodies. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220127375A1 (en) |
| EP (1) | EP3924377A1 (en) |
| JP (2) | JP7375027B2 (en) |
| KR (1) | KR20210126699A (en) |
| AU (1) | AU2020221649A1 (en) |
| BR (1) | BR112021016092A2 (en) |
| CA (1) | CA3130246A1 (en) |
| IL (1) | IL285489A (en) |
| MA (1) | MA54943A (en) |
| MX (1) | MX2021009769A (en) |
| SG (1) | SG11202108840XA (en) |
| TW (1) | TW202045132A (en) |
| WO (1) | WO2020167122A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3649156A1 (en) * | 2017-07-06 | 2020-05-13 | Merus N.V. | Antibodies that modulate a biological activity expressed by a cell |
| US20220281914A1 (en) * | 2020-12-18 | 2022-09-08 | Kiniksa Pharmaceuticals, Ltd. | Protein compositions and methods for producing and using the same |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003267135A1 (en) * | 2002-09-17 | 2004-04-08 | Gtc Biotherapeutics, Inc. | Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds |
| WO2004106375A1 (en) | 2003-05-30 | 2004-12-09 | Merus Biopharmaceuticals B.V. I.O. | Fab library for the preparation of anti vegf and anti rabies virus fabs |
| EP2471816A1 (en) | 2006-08-30 | 2012-07-04 | Genentech, Inc. | Multispecific antibodies |
| EP3456190B1 (en) | 2008-06-27 | 2021-11-24 | Merus N.V. | Antibody producing transgenic murine animal |
| SG174378A1 (en) | 2009-03-20 | 2011-10-28 | Genentech Inc | Bispecific anti-her antibodies |
| SI2522724T1 (en) * | 2009-12-25 | 2020-07-31 | Chuqai Seiyaku Kabushiki Kaisha | Polypeptide modification method for purifying polypeptide multimers |
| PT2838917T (en) | 2012-04-20 | 2019-09-12 | Merus Nv | Methods and means for the production of heterodimeric ig-like molecules |
| BR112016003196A8 (en) * | 2013-08-19 | 2020-02-04 | Hoffmann La Roche | method for separating bispecific antibodies |
| KR102661320B1 (en) * | 2017-06-05 | 2024-05-03 | 얀센 바이오테크 인코포레이티드 | Surface charge manipulation method for generating bispecific antibodies |
-
2020
- 2020-02-13 AU AU2020221649A patent/AU2020221649A1/en active Pending
- 2020-02-13 SG SG11202108840XA patent/SG11202108840XA/en unknown
- 2020-02-13 US US17/431,041 patent/US20220127375A1/en active Pending
- 2020-02-13 MX MX2021009769A patent/MX2021009769A/en unknown
- 2020-02-13 KR KR1020217029450A patent/KR20210126699A/en unknown
- 2020-02-13 CA CA3130246A patent/CA3130246A1/en active Pending
- 2020-02-13 WO PCT/NL2020/050080 patent/WO2020167122A1/en unknown
- 2020-02-13 MA MA054943A patent/MA54943A/en unknown
- 2020-02-13 EP EP20709758.5A patent/EP3924377A1/en active Pending
- 2020-02-13 BR BR112021016092-2A patent/BR112021016092A2/en unknown
- 2020-02-13 JP JP2021547742A patent/JP7375027B2/en active Active
- 2020-02-14 TW TW109104781A patent/TW202045132A/en unknown
-
2021
- 2021-08-10 IL IL285489A patent/IL285489A/en unknown
-
2023
- 2023-10-05 JP JP2023173552A patent/JP2023171492A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3924377A1 (en) | 2021-12-22 |
| TW202045132A (en) | 2020-12-16 |
| US20220127375A1 (en) | 2022-04-28 |
| CA3130246A1 (en) | 2020-08-20 |
| JP2022520972A (en) | 2022-04-04 |
| JP7375027B2 (en) | 2023-11-07 |
| MA54943A (en) | 2021-12-22 |
| AU2020221649A1 (en) | 2021-09-02 |
| MX2021009769A (en) | 2021-09-08 |
| WO2020167122A1 (en) | 2020-08-20 |
| KR20210126699A (en) | 2021-10-20 |
| JP2023171492A (en) | 2023-12-01 |
| IL285489A (en) | 2021-09-30 |
| BR112021016092A2 (en) | 2021-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277072A (en) | Anti-claudin 18.2 antibodies | |
| MX2019007021A (en) | Il-11ra antibodies. | |
| SG11202108141VA (en) | Novel cd40-binding antibodies | |
| IL283754A (en) | Anti-claudin antibodies, compositions comprising same and uses thereof | |
| EP4017883A4 (en) | Novel anti-cldn18.2 antibodies | |
| IL289112A (en) | Anti-tigit antibodies | |
| IL280809B (en) | Novel compositions, their use, and methods for their formation | |
| EP3692072A4 (en) | Anti-hla-dq2.5 antibody | |
| IL285651A (en) | Anti-trem2 antibodies, compositions comprising same and uses thereof | |
| IL291068A (en) | Anti-cd73 antibodies | |
| IL284584A (en) | Anti-tigit antibodies | |
| WO2017011340A3 (en) | Proteins and immunizing compositions containing klebsiella proteins and methods of use | |
| WO2017021539A3 (en) | Novel anti-human gpvi antibodies and uses thereof | |
| IL284800A (en) | Methods, uses & compositions | |
| IL287828A (en) | Anti-epha4 antibody | |
| IL285489A (en) | Producing compositions comprising two or more antibodies | |
| EP3947466A4 (en) | Anti-hla-dq2.5 antibody | |
| GB201905150D0 (en) | Ant-ige antibodies | |
| GB201917480D0 (en) | Antibodies | |
| EP3858994A4 (en) | Antibody composition | |
| GB201900732D0 (en) | Antibodies | |
| IL289160A (en) | Anti-angpt2 antibodies | |
| GB202015822D0 (en) | 66.123.142648/01 | |
| EP4081539A4 (en) | Novel anti-fgfr2b antibodies | |
| EP4081547A4 (en) | Novel anti-fgfr2b antibodies |